Literature DB >> 19361222

High-relaxivity gadolinium-modified high-density lipoproteins as magnetic resonance imaging contrast agents.

Karen C Briley-Saebo1, Simonetta Geninatti-Crich, David P Cormode, Alessandra Barazza, Willem J M Mulder, Wei Chen, Giovanni B Giovenzana, Edward A Fisher, Silvio Aime, Zahi A Fayad.   

Abstract

There is an ongoing desire to produce high-relaxivity, Gd-based magnetic resonance imaging (MRI) contrast agents. These may allow for lower doses to be used, which is especially important in view of the current safety concerns surrounding Gd in patients. Here we report the synthesis of a high-relaxivity MRI contrast agent, by incorporating Gd-chelating lipids that coordinate two water molecules into high-density lipoprotein (q = 2 HDL). We compared the properties of q = 2 HDL with those of an analogous HDL particle labeled with Gd-chelating lipids that coordinate only one water molecule (q = 1 HDL). We found that the q = 2 HDL possessed an elevated r(1) of 41 mM(-1) s(-1) compared to 9 mM(-1) s(-1) for q = 1 HDL at 20 MHz, but the q = 2 HDL exhibited high R(2)* values at high fields, precluding imaging above 128 MHz. While carrying out this investigation we observed that enlarged, disrupted particles were formed when the synthesis was carried out above the lipid critical micelle concentration (cmc), indicating the importance of synthesis below the cmc when modifying lipoproteins in this manner. The high relaxivity of q = 2 HDL means it will be an efficacious contrast agent for future MR imaging studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19361222      PMCID: PMC2688742          DOI: 10.1021/jp8108286

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  32 in total

Review 1.  Molecular imaging.

Authors:  R Weissleder; U Mahmood
Journal:  Radiology       Date:  2001-05       Impact factor: 11.105

2.  The relationship between thermodynamics and the toxicity of gadolinium complexes.

Authors:  W P Cacheris; S C Quay; S M Rocklage
Journal:  Magn Reson Imaging       Date:  1990       Impact factor: 2.546

3.  Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques.

Authors:  Juan C Frias; Kevin Jon Williams; Edward A Fisher; Zahi A Fayad
Journal:  J Am Chem Soc       Date:  2004-12-22       Impact factor: 15.419

Review 4.  Next generation, high relaxivity gadolinium MRI agents.

Authors:  Kenneth N Raymond; Valérie C Pierre
Journal:  Bioconjug Chem       Date:  2005 Jan-Feb       Impact factor: 4.774

5.  Multilocus binding increases the relaxivity of protein-bound MRI contrast agents.

Authors:  Zhaoda Zhang; Matthew T Greenfield; Marga Spiller; Thomas J McMurry; Randall B Lauffer; Peter Caravan
Journal:  Angew Chem Int Ed Engl       Date:  2005-10-21       Impact factor: 15.336

Review 6.  Multimodality nanotracers for cardiovascular applications.

Authors:  Willem J M Mulder; David P Cormode; Sjoerd Hak; Mark E Lobatto; Stephane Silvera; Zahi A Fayad
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-08

7.  Nondenaturing polyacrylamide gradient gel electrophoresis.

Authors:  A V Nichols; R M Krauss; T A Musliner
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

8.  Substituent effects on Gd(III)-based MRI contrast agents: optimizing the stability and selectivity of the complex and the number of coordinated water molecules.

Authors:  Valérie C Pierre; Mauro Botta; Silvio Aime; Kenneth N Raymond
Journal:  Inorg Chem       Date:  2006-10-02       Impact factor: 5.165

Review 9.  Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes.

Authors:  Karen C Briley-Saebo; Willem J M Mulder; Venkatesh Mani; Fabien Hyafil; Vardan Amirbekian; Juan Gilberto S Aguinaldo; Edward A Fisher; Zahi A Fayad
Journal:  J Magn Reson Imaging       Date:  2007-09       Impact factor: 4.813

10.  Lipoprotein electrostatic properties regulate hepatic lipase association and activity.

Authors:  Jonathan G Boucher; Trang Nguyen; Daniel L Sparks
Journal:  Biochem Cell Biol       Date:  2007-12       Impact factor: 3.626

View more
  13 in total

1.  HDL as a contrast agent for medical imaging.

Authors:  David P Cormode; Juan C Frias; Yanqing Ma; Wei Chen; Torjus Skajaa; Karen Briley-Saebo; Alessandra Barazza; Kevin Jon Williams; Willem Jm Mulder; Zahi A Fayad; Edward A Fisher
Journal:  Clin Lipidol       Date:  2009-08

2.  Z-Group ketone chain transfer agents for RAFT polymer nanoparticle modification via hydrazone conjugation.

Authors:  Saibal Bandyopadhyay; Xin Xia; Andrei Maiseiyeu; Georgeta Mihai; Sanjay Rajagopalan; Dennis Bong
Journal:  Macromolecules       Date:  2012-08-30       Impact factor: 5.985

Review 3.  Engineering Gd-loaded nanoparticles to enhance MRI sensitivity via T(1) shortening.

Authors:  Michael A Bruckman; Xin Yu; Nicole F Steinmetz
Journal:  Nanotechnology       Date:  2013-10-24       Impact factor: 3.874

4.  Single step reconstitution of multifunctional high-density lipoprotein-derived nanomaterials using microfluidics.

Authors:  YongTae Kim; Francois Fay; David P Cormode; Brenda L Sanchez-Gaytan; Jun Tang; Elizabeth J Hennessy; Mingming Ma; Kathryn Moore; Omid C Farokhzad; Edward Allen Fisher; Willem J M Mulder; Robert Langer; Zahi A Fayad
Journal:  ACS Nano       Date:  2013-10-03       Impact factor: 15.881

Review 5.  Imaging of oxidation-specific epitopes with targeted nanoparticles to detect high-risk atherosclerotic lesions: progress and future directions.

Authors:  Karen Briley-Saebo; Calvin Yeang; Joseph L Witztum; Sotirios Tsimikas
Journal:  J Cardiovasc Transl Res       Date:  2014-10-09       Impact factor: 4.132

Review 6.  Modified natural nanoparticles as contrast agents for medical imaging.

Authors:  David P Cormode; Peter A Jarzyna; Willem J M Mulder; Zahi A Fayad
Journal:  Adv Drug Deliv Rev       Date:  2009-11-06       Impact factor: 15.470

Review 7.  Lipoproteins and lipoprotein mimetics for imaging and drug delivery.

Authors:  C Shad Thaxton; Jonathan S Rink; Pratap C Naha; David P Cormode
Journal:  Adv Drug Deliv Rev       Date:  2016-04-29       Impact factor: 15.470

Review 8.  High-density lipoprotein-based contrast agents for multimodal imaging of atherosclerosis.

Authors:  Torjus Skajaa; David P Cormode; Erling Falk; Willem J M Mulder; Edward A Fisher; Zahi A Fayad
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-10-08       Impact factor: 8.311

9.  Gd(III)-nanodiamond conjugates for MRI contrast enhancement.

Authors:  Lisa M Manus; Daniel J Mastarone; Emily A Waters; Xue-Qing Zhang; Elise A Schultz-Sikma; Keith W Macrenaris; Dean Ho; Thomas J Meade
Journal:  Nano Lett       Date:  2010-02-10       Impact factor: 11.189

10.  Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation.

Authors:  Jun Tang; Mark E Lobatto; Laurien Hassing; Susanne van der Staay; Sarian M van Rijs; Claudia Calcagno; Mounia S Braza; Samantha Baxter; Francois Fay; Brenda L Sanchez-Gaytan; Raphaël Duivenvoorden; Hendrik Sager; Yaritzy M Astudillo; Wei Leong; Sarayu Ramachandran; Gert Storm; Carlos Pérez-Medina; Thomas Reiner; David P Cormode; Gustav J Strijkers; Erik S G Stroes; Filip K Swirski; Matthias Nahrendorf; Edward A Fisher; Zahi A Fayad; Willem J M Mulder
Journal:  Sci Adv       Date:  2015-04       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.